Reaction

Gingival Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,816 reports · 94 co-occurring drugs

As of the last recalculation, Gingival Disorder appears in 3,816 FAERS reports alongside 94 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 25.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alendronate Sodium	419	25.3	25.4
Magnesium Sulfate In Water For	49	21.2	21.3
Magnesium Sulfate Heptahydrate	49	20.8	20.8
Magnesium Sulfate	49	20.7	20.8
Extended Phenytoin Sodium	61	20.2	20.3
Ciclesonide	48	19.5	19.5
Risedronate Sodium	65	11.6	11.6
Phenytoin	43	11.4	11.4
Chlorhexidine Gluconate	18	10.8	10.8
Denosumab	332	9.7	9.7
Nicotine Polacrilex	56	8.1	8.1
Raloxifene Hydrochloride	17	6.4	6.4
Zoledronic Acid	46	6.3	6.3
Primidone	11	5.9	5.9
Sunitinib Malate	42	5.9	5.9
Tiotropium Bromide Inhalation Spray	12	5.9	5.9
Phenobarbital	15	5.7	5.7
Romosozumab-Aqqg	14	5.6	5.6
Vitamin E	32	5.6	5.6
Fluticasone Propionate And Salmeterol Xinafoate	59	5.4	5.4
Bisacodyl Suppositories	12	5.1	5.1
Biscodyl	12	5.0	5.0
Buprenorphine Hydrochloride, Naloxone Hydrochloride	22	5.0	5.0
Anastrozole	33	4.9	4.9
Brivaracetam	8	4.9	4.9
Exemestane	19	4.9	4.9
Rizatriptan Benzoate	9	4.8	4.8
Anti-Itch	58	4.8	4.8
Anti-Pruritic	58	4.8	4.8
Antipruritic (Anti-Itch)	58	4.8	4.8
Cool Relief Gel With Aloe	58	4.8	4.8
Drs. Hydrocortisone	58	4.8	4.8
Hydrocortisone Continuous Spray	58	4.8	4.8
Hydrocortisone Spray	58	4.8	4.8
Anti-Itch Cream	58	4.8	4.8
Hydrocortisone Lotion	58	4.8	4.8
Hydrocortisone Cream 1%	58	4.8	4.8
Hydrocortisone Cream 1/2%	58	4.8	4.8
Hydrocortisone 1%	58	4.8	4.8
Hydrocortisone Cream	58	4.8	4.8
Bisacodyl	12	4.7	4.7
Fulvestrant	27	4.5	4.5
Zonisamide	12	4.4	4.4
Rabeprazole Sodium	22	4.4	4.4
Letrozole	49	4.4	4.4
Ciprofloxacin Hydrochloride And Hydrocortisone	16	4.2	4.2
Infliximab-Dyyb	22	4.1	4.1
Fluticasone Furoate	9	4.1	4.1
Calcium	108	4.1	4.1
Bicalutamide	11	3.9	3.9
Sennosides 8.6 Mg Tablets	15	3.9	3.9
Senna	15	3.9	3.9
Salmeterol Xinafoate	6	3.8	3.8
Thalidomide	25	3.7	3.7
Conjugated Estrogens	39	3.7	3.7
Goserelin	9	3.7	3.7
Lansoprazole	114	3.6	3.6
Fesoterodine Fumarate	7	3.5	3.5
Estrogens, Conjugated	38	3.5	3.5
Finasteride	36	3.3	3.3
Nicotine	24	3.3	3.3
Cabozantinib	28	3.2	3.2
Vigabatrin	8	3.0	3.0
Ribociclib	17	2.9	2.9
Teriparatide	60	2.9	2.9
Loratadine And Pseudoephedrine Sulfate	4	2.7	2.7
Fluticasone Furoate And Vilanterol Trifenatate	17	2.6	2.6
Peginterferon Alfa-2A	25	2.5	2.5
Brinzolamide	4	2.5	2.5
Alpelisib	4	2.5	2.5
Gefitinib	4	2.4	2.4
Armodafinil	9	2.3	2.3
Palbociclib	40	2.3	2.3
Niraparib	9	2.2	2.2
Ribavirin	24	2.0	2.0
Rucaparib	3	1.9	1.9
Conjugated Estrogens And Medroxyprogesterone Acetate	8	1.9	1.9
Avapritinib	4	1.8	1.8
Varenicline Tartrate	26	1.8	1.8
Lenvatinib	10	1.7	1.7
Encorafenib	3	1.7	1.7
Cannabidiol	7	1.6	1.6
Pomalidomide	28	1.5	1.5
Enzalutamide	16	1.5	1.5
Dasatinib	10	1.5	1.5
Axitinib	5	1.4	1.4
Relugolix	6	1.4	1.4
Abiraterone Acetate	10	1.3	1.3
Lenalidomide	101	1.3	1.3
Orlistat	5	1.1	1.1
Hydrocodone Bitartrate	8	1.0	1.0
Abaloparatide	5	0.9	0.9
Nirmatrelvir And Ritonavir	8	0.8	0.8
Adapalene	3	0.1	0.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.